Teva Releases Q3 2025 Aide Memoire

Core Points - Teva Pharmaceutical Industries Ltd. has released its Q3 2025 Aide Memoire, which is available on the company's "Investors" page [1] - The Aide Memoire is designed to assist in financial modeling of Teva's quarterly results, based on prior results and management's commentary [2] Company Overview - Teva is a leading innovative biopharmaceutical company with a strong generics business, committed to addressing patients' needs for over 120 years [3] - The company focuses on innovation in neuroscience and immunology, as well as providing complex generic medicines, biosimilars, and pharmacy brands globally [3]